Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
, 22 (13), 3602-10

Total Mesorectal Excision for Mid and Low Rectal Cancer: Laparoscopic vs Robotic Surgery

Comparative Study

Total Mesorectal Excision for Mid and Low Rectal Cancer: Laparoscopic vs Robotic Surgery

Francesco Feroci et al. World J Gastroenterol.


Aim: To compare the short- and long-term outcomes of laparoscopic and robotic surgery for middle and low rectal cancer.

Methods: This is a retrospective study on a prospectively collected database containing 111 patients who underwent minimally invasive rectal resection with total mesorectal excision (TME) with curative intent between January 2008 and December 2014 (robot, n = 53; laparoscopy, n = 58). The patients all had a diagnosis of middle and low rectal adenocarcinoma with stage I-III disease. The median follow-up period was 37.4 mo. Perioperative results, morbidity a pathological data were evaluated and compared. The 3-year overall survival and disease-free survival rates were calculated and compared.

Results: Patients were comparable in terms of preoperative and demographic parameters. The median surgery time was 192 min for laparoscopic TME (L-TME) and 342 min for robotic TME (R-TME) (P < 0.001). There were no differences found in the rates of conversion to open surgery and morbidity. The patients who underwent laparoscopic surgery stayed in the hospital two days longer than the robotic group patients (8 d for L-TME and 6 d for R-TME, P < 0.001). The pathologic evaluation showed a higher number of harvested lymph nodes in the robotic group (18 for R-TME, 11 for L-TME, P < 0.001) and a shorter distal resection margin for laparoscopic patients (1.5 cm for L-TME, 2.5 cm for R-TME, P < 0.001). The three-year overall survival and disease-free survival rates were similar between groups.

Conclusion: Both L-TME and R-TME achieved acceptable clinical and oncologic outcomes. The robotic technique showed some advantages in rectal surgery that should be validated by further studies.

Keywords: Laparoscopic surgery; Minimally invasive surgery; Rectal cancer; Robotic surgery; Total mesorectal excision.


Figure 1
Figure 1
The 3-year overall (A) and disease-free (B) survival rate between robotic and laparoscopic total mesorectal excision surgical procedures. DTS: Disease-free survival; OS: Overall survival; L-TME: Laparoscopic total mesorectal excision; R-TME: Robotic total mesorectal excision.

Similar articles

See all similar articles

Cited by 11 PubMed Central articles

See all "Cited by" articles

Publication types

MeSH terms